Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GUADECITABINE: 81 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
81
Total FAERS Reports
29 (35.8%)
Deaths Reported
52
Hospitalizations
81
As Primary/Secondary Suspect
6
Life-Threatening

First Report: 20160123 · Latest Report: 20211018

What Are the Most Common GUADECITABINE Side Effects?

#1 Most Reported
Febrile neutropenia
21 reports (25.9%)
#2 Most Reported
Neutropenia
16 reports (19.8%)
#3 Most Reported
Thrombocytopenia
12 reports (14.8%)

All GUADECITABINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Febrile neutropenia 21 25.9% 3 17
Neutropenia 16 19.8% 2 9
Anaemia 12 14.8% 5 9
Thrombocytopenia 12 14.8% 1 5
Constipation 11 13.6% 1 8
Neutrophil count decreased 9 11.1% 6 6
Abdominal pain 8 9.9% 2 8
Fatigue 8 9.9% 4 4
Platelet count decreased 8 9.9% 5 6
Sepsis 8 9.9% 8 5
Back pain 7 8.6% 1 7
Nausea 7 8.6% 2 2
Pneumonia 7 8.6% 4 7
Urinary tract infection 7 8.6% 0 7
Vomiting 7 8.6% 5 5
White blood cell count decreased 7 8.6% 1 3
Hyponatraemia 6 7.4% 3 4
Injection site reaction 6 7.4% 2 2
Pelvic pain 6 7.4% 0 6
Pyrexia 6 7.4% 0 5

Who Reports GUADECITABINE Side Effects? Age & Gender Data

Gender: 28.8% female, 71.2% male. Average age: 61.4 years. Most reports from: US. View detailed demographics →

Is GUADECITABINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 1 0 1
2017 5 1 4
2018 17 8 17
2019 23 8 21
2020 6 3 5
2021 4 0 0

View full timeline →

What Is GUADECITABINE Used For?

IndicationReports
Myelodysplastic syndrome 21
Product used for unknown indication 9
Ovarian cancer recurrent 7
Transitional cell carcinoma metastatic 6
Acute myeloid leukaemia 5
Chronic myelomonocytic leukaemia 5
Leukaemia 5

Official FDA Label for GUADECITABINE

Official prescribing information from the FDA-approved drug label.